Poster Presentations the cartilage. The purpose of the current study was to determine the effect of IL-1 on global gene expression in chondrocytes from individuals with no history of OA and chondrocytes from cartilage with patients with OA. Methods: Chondrocytes were isolated from cartilage of a donor greater than 60 years without history of OA, intact cartilage from total joint arthroplasty (OA) and a young adult without OA, and cultured at 106 cells/cm2. IL-1 was added at concentrations of 2 ng/ml for some experiments and 0.1, 1 and 10 ng/ml for other experiments. In some cultures IL-1 was removed at 24 hrs and the anabolic factors BMP-2 and TGF-beta1 were added and cultured for an additional 24 hrs. RNA was isolated by the Trizol method and cDNA was prepared for microarray analysis using cDNA arrays of 20,000 human gene transcripts. Microarray data was verified using semi-quantitative RT-PCR. Results: Microarray analysis suggested that a large set of chemokine genes were the most highly responsive to IL-1 stimulating begin increased 25-75 fold by 2 ng/ml (see Table 1 ). A second set of chemokines was increased 3-11 fold. The increase was observed down to a level of 100 pg/ml IL-1. As expected type II collagen gene expression decreased by 50% and MMP-13 expression increased 6 fold. Surprisingly, expression of the aggrecanase, ADAMS-TS5, was present in all cartilages examined and down-regulated in normal cartilage by 7 fold and in OA cartilage approximately 5 fold. All results were confirmed by RT-PCR. BMP-2 was increased by 4 fold. IL-1 autoregulated its own gene by 20 fold.
When the concentration of IL-1 was reduced to 100 pg/ml, the chemokines were increased while the other effects of IL-1 were reduced. The same result was observed in all ages of normal cartilage. For the OA cartilage, gene expression was similar as the low concentrations of IL-1, however, with addition of IL-1, the effects were more dramatic. Interestingly, only TGF-BETA could reverse some, but not all effects. Conclusions: Two distinct sets of chemokines were the most highly responsive of all cartilage genes to culture with IL-1. The effects of IL-1 on other genes vary with the concentration of the cytokine, but the chemokines are the most responsive. This indicates that at these genes are differentially regulated. Surprisingly, the aggrecanase gene ADAMS-TS5 was present in all chondrocytes and down-regulated by IL-1. While the expected effects of IL-1 were observed, other previously unknown effects were observed. In addition, these experiments clearly demonstrate that reactions vary by concentration. Thus even more complex effects of inflammation on cartilage are revealed. Purpose: Calcitonin has been suggested to have chondroprotective effects in joint degenerative diseases. In vitro studies have demonstrated that one signalling pathway of calcitonin is via the second messenger cAMP. We investigated whether increased cAMP levels in chondrocytes would be chondroprotective in a model of cartilage degradation. Methods: Cartilage degradation was induced in bovine articular cartilage explants cultures by stimulation with 10 ng/mL oncostatin M (OSM) and 20 ng/mL TNF. cAMP levels was stimulated by treatment with either forskolin (cAMP activator, 1-64 μM) or IBMX (phosphodiesterase inhibitor, 1-64 μM), and the intracellular cAMP levels were evaluated by ELISA. Cartilage degradation was evaluated in the conditioned medium by quantification of crosslinked C-telopeptide fragments of type II collagen (CTX-II), matrix metalloproteinase (MMP) mediated aggrecan turnover by a novel ELISA detecting the 342 FFGVG-G2 cleavage site, aggrecanase mediated aggrecan turnover by a novel ARGS-G2 ELISA. Biochemical findings were validated by immunohistochemistry of CTX-II fragments and toluidine blue stainings of proteoglycans. Changes in MMP expression and activity in the conditioned medium were assessed by gelatine zymography. Alamarblue was used to evaluate cyto-toxicity after stimulation with the various compounds and cytokines. Results: OSM and TNF treatment induced a 500-fold increase in CTX-II release to the supernatant (P<0.001) compared to vehicle control. Both forskolin and IBMX dose-dependently inhibited CTX-II release (P<0.001), which at the highest concentration was completely abrogated. OSM and TNF induced 8 fold increase in MMP mediated aggrecan degradation (FFGV-G2), which was dose-dependently inhibited by both forskolin and IBMX to 75%, (P<0.001). OSM and TNF evoked marked increases in MMP expression, which was dose-dependently inhibited by both forskolin and IBMX. With regards to aggrecanase activity, OSM and TNF induced a 4 fold increase in ARGS-G2 degradation products of aggrecan. Forskolin significantly inhibited aggrecanase mediated aggrecan degradation by 60% (P<0.01), whereas IBMX inhibited aggrecanase activity by 40% albeit non-significant. None of the compounds affected cell number or viability. Conclusions: cAMP levels in chondrocytes play a key role in controlling the catabolic activity. Increased cAMP levels in chondrocytes results in inhibition of aggrecanase as well as MMP expression and activity, and consequently a strong inhibition of cartilage degradation. Specific cAMP modulators in chondrocytes, such as calcitonin, may be potential treatments for cartilage degenerative diseases.
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